Business · 11/08/2020Updated: 10/17/2026 · 1 min read
FDA Announces Final Guidance for Marketing Status Notifications Under FD&C Act
Summary
The FDA has released a final guidance document to help pharmaceutical companies comply with marketing status notifications required under the Federal Food, Drug, and Cosmetic Act, building on a previously issued draft guidance from January 31, 2019.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →